Results 221 to 230 of about 482,699 (357)
Geometric Adjustment of T Cell‐Sensitive Nanorobots for Enhanced Stability
For the long‐term use of live dendritic cell (DC)‐based vaccines, nano bone marrow dendritic cell (BMDC) originated T cell activators (nano‐BOTs) are synthesized. The geometric properties of nanoparticles are precisely modulated, enhancing their stability and T cell activation capacity.
Yoojin Lee+11 more
wiley +1 more source
Immunotherapy / Gene therapy / AIDS and cancer
Jean-Luc Darilx+2 more
openalex +1 more source
Exosomes: a double-edged sword in cancer immunotherapy. [PDF]
Chen J+5 more
europepmc +1 more source
Beta‐glucans have gained significant attention as an immunomodulatory biomaterial with cell‐targeting capabilities. This review comprehensively outlines the design and fabrication methods for producing beta‐glucan particles at both the micro and nanoscale and their applications in immune cell targeting, immunomodulation, and drug delivery ...
Nate Dowdall, Todd Hoare
wiley +1 more source
Cancer immunotherapy in clinical oncology [PDF]
Alexander Knuth+2 more
openalex +1 more source
A mitochondria‐targeted cationic nanoscale metal organic framework shows strong radiotherapy‐radiodynamic therapy effects and selectively releases digitonin in acidic tumor microenvironments to induce disulfidptosis of cancer cells and downregulate immune checkpoints in cancer and T cells, thereby eliciting strong antitumor immunity to effectively ...
Wenyao Zhen+7 more
wiley +1 more source
Efficacy and Safety of Bacille Calmette-Guérin Immunotherapy in Superficial Bladder Cancer [PDF]
Donald L. Lamm
openalex +1 more source
Cytokine-centered strategies to boost cancer immunotherapy. [PDF]
Manzano S, Caffarel MM.
europepmc +1 more source
Engineering CAR‐T Therapeutics for Enhanced Solid Tumor Targeting
CART cell therapy has proven effective for blood cancers but struggles with solid tumors due to diverse antigens and complex environments. Recent efforts focus on improving CAR design and validation platforms. Advances in protein engineering, machine learning, and organoid systems aim to enhance CAR‐T therapy against solid tumors.
Danqing Zhu+4 more
wiley +1 more source